HIRM Advisory Boards


The HMS Initiative for RNA Medicine receives support and guidance from two committees:

Director’s Advisory Board

In consultation with the BIDMC Office of Development, members of the HIRM Director’s Advisory Board develop understanding of achievements and challenges in RNA medicine, assess effectiveness of existing initiatives, and encourage exploration of new projects. The Director’s Advisory Board provides strategic advisement and critical philanthropic support for groundbreaking basic and translational research and clinical enterprises.

Business Advisory Board

This group participates in confidential technical discussions with HIRM faculty members on new approaches and discoveries about the role of RNA in human biology and disease. Business Advisory Board members guide the development of HIRM collaborations with industry partners and help shape the direction of HIRM members’ scientific and clinical research. Participation in the Business Advisory Board is by invitation only.

For more information, please contact Hilary Prosnitz at hprosnit@bidmc.harvard.edu.